BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 30315285)

  • 1. Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Moctezuma-Velazquez C; Saffioti F; Tasayco-Huaman S; Casu S; Mason A; Roccarina D; Vargas V; Nilsson JE; Tsochatzis E; Augustin S; Montano-Loza AJ; Berzigotti A; Thorburn D; Genesca J; Abraldes JG
    Am J Gastroenterol; 2019 Mar; 114(3):446-452. PubMed ID: 30315285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
    Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
    J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
    Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
    J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease.
    Galizzi HO; Couto CA; Taranto DOL; Araújo SIO; Vilela EG
    Ann Hepatol; 2021; 20():100229. PubMed ID: 32745630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
    Sharma S; Agarwal S; Gunjan D; Kaushal K; Anand A; Saraya A
    Am J Gastroenterol; 2020 Oct; 115(10):1650-1656. PubMed ID: 32516202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
    Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
    Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
    Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
    Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.
    Tosetti G; Primignani M; La Mura V; D'Ambrosio R; Degasperi E; Mezzina N; Viganò M; Rumi M; Fracanzani AL; Lombardi R; Fargion S; Fraquelli M; Aghemo A; Lampertico P
    Dig Liver Dis; 2019 Aug; 51(8):1135-1140. PubMed ID: 30691777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.
    Lee HA; Kim SU; Seo YS; Lee YS; Kang SH; Jung YK; Kim MY; Kim JH; Kim SG; Suk KT; Jung SW; Jang JY; An H; Yim HJ; Um SH
    Liver Int; 2019 Jun; 39(6):1071-1079. PubMed ID: 30589490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
    Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
    Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
    Gaete MI; Díaz LA; Arenas A; González K; Cattaneo M; Fuster F; Henríquez R; Soza A; Arrese M; Barrera F; Arab JP; Benítez C
    Liver Int; 2020 Jun; 40(6):1427-1434. PubMed ID: 31916360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elastography-based screening for esophageal varices in patients with advanced chronic liver disease.
    Paternostro R; Reiberger T; Bucsics T
    World J Gastroenterol; 2019 Jan; 25(3):308-329. PubMed ID: 30686900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.
    Stafylidou M; Paschos P; Katsoula A; Malandris K; Ioakim K; Bekiari E; Haidich AB; Akriviadis E; Tsapas A
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1744-1755.e11. PubMed ID: 31077823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.
    Augustin S; Pons M; Maurice JB; Bureau C; Stefanescu H; Ney M; Blasco H; Procopet B; Tsochatzis E; Westbrook RH; Bosch J; Berzigotti A; Abraldes JG; Genescà J
    Hepatology; 2017 Dec; 66(6):1980-1988. PubMed ID: 28696510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
    Zhou H; Long J; Hu H; Tian CY; Lin SD
    World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Course of oesophageal varices and performance of noninvasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease.
    Giannini EG; De Maria C; Crespi M; Demarzo MG; Fazio V; Grasso A; Torre F; Bodini G; Marabotto E; Furnari M
    Eur J Clin Invest; 2020 May; 50(5):e13231. PubMed ID: 32291753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
    Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
    J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience.
    Calvaruso V; Cacciola I; Licata A; Madonia S; Benigno R; Petta S; Bronte F; Conte E; Malizia G; Bertino G; Distefano M; Montineri A; Digiacomo A; Alaimo G; Cacopardo B; Davì A; Guarneri L; Scalisi I; Colletti P; Cartabellotta F; Portelli V; Prestileo T; Averna A; Iacobello C; Mondello L; Scifo G; Russello M; Squadrito G; Raimondo G; Cammà C; Craxì A; Di Marco V;
    Am J Gastroenterol; 2019 Aug; 114(8):1275-1282. PubMed ID: 31135449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Baveno VI criteria to rule out high-risk varices using hepatic shear-wave elastography.
    Castro Filho ÉC; Fernandes FF; Villela-Nogueira C; Madeira E; Barros F; Luz R; Pereira GH; Perazzo H
    Eur J Gastroenterol Hepatol; 2023 May; 35(5):559-567. PubMed ID: 36966754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.
    Bae J; Sinn DH; Kang W; Gwak GY; Choi MS; Paik YH; Lee JH; Koh KC; Paik SW
    Liver Int; 2018 Aug; 38(8):1442-1448. PubMed ID: 29495113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.